Search

Your search keyword '"Franck Boccara"' showing total 171 results

Search Constraints

Start Over You searched for: Author "Franck Boccara" Remove constraint Author: "Franck Boccara" Topic medicine Remove constraint Topic: medicine
171 results on '"Franck Boccara"'

Search Results

1. Control of Low-Density Lipoprotein Cholesterol in Secondary Prevention of Coronary Artery Disease in Real-Life Practice: The DAUSSET Study in French Cardiologists

2. Trends in the risk of myocardial infarction among HIV-1-infected individuals relative to the general population in France: Impact of gender and immune status.

3. Dissection aortique anévrismale chez un adulte infecté par le VIH-1 dans le cadre d'un syndrome de reconstitution immune avec tuberculose

4. Is Impact of Statin Therapy on All-Cause Mortality Different in HIV-Infected Individuals Compared to General Population? Results from the FHDH-ANRS CO4 Cohort.

5. Association of residual plasma viremia and intima-media thickness in antiretroviral-treated patients with controlled human immunodeficiency virus infection.

6. The Added Value of Coronary Calcium Score in Predicting Cardiovascular Events in Familial Hypercholesterolemia

7. Acute Myocarditis Revealing Adult-Onset Still’s Disease

8. Does layer-specific strain using speckle tracking echocardiography improve the assessment of left ventricular myocardial deformation? A review

9. Proposal for a standardized discharge letter after hospital stay for acute myocardial infarction

10. Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial

11. Evolocumab in HIV-Infected Patients With Dyslipidemia

12. Lipoprotein(a): Pathophysiology, measurement, indication and treatment in cardiovascular disease. A consensus statement from the Nouvelle Société Francophone d’Athérosclérose (NSFA)

13. Atherosclerotic Cardiovascular Events in Patients Infected With Human Immunodeficiency Virus and Hepatitis C Virus

14. Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

15. Cardiovascular complications of lipodystrophic syndromes – focus on laminopathies

16. Never too old for lipid-lowering therapy

17. Development and Validation of a New Risk Prediction Score for Life-Threatening Ventricular Tachyarrhythmias in Laminopathies

18. Un risque thrombotique persistant malgré les traitements de référence

19. Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

20. Abstract 15146: Reverse Right Heart Chambers Remodeling and Decrease in Tricuspid Regurgitation Severity After Restoration of Sinus Rhythm in Patients With Atrial Fibrillation: A Mid-term 3d Echocardiographic Study

21. Restoration of normal sinus rhythm in atrial fibrillation: impact of reverse remodelling of right chambers on tricuspid regurgitation severity

22. Impact of rhythm in non-valvular atrial fibrillation on four cardiac chamber deformation imaging

23. Prognosis of acute kidney injury during acute heart failure: the role of diuretics

24. Fraction d’éjection ventriculaire gauche un marqueur de risqué additionnel dans la COVID-19

25. Hospital admissions for acute myocardial infarction before and after lockdown according to regional prevalence of COVID-19 and patient profile in France: a registry study

26. HIV Infection and Long-Term Residual Cardiovascular Risk After Acute Coronary Syndrome

27. SAFEHEART risk-equation and cholesterol-year-score are powerful predictors of cardiovascular events in French patients with familial hypercholesterolemia

28. Blunting periprocedural myocardial necrosis: Rationale and design of the randomized ALPHEUS study

29. TO019PROGNOSTIC VALUE OF ACUTE KIDNEY INJURY AND HEMOCONCENTRATION DURING ACUTE HEART FAILURE

30. Looking at New Unexpected Disease Targets in LMNA-Linked Lipodystrophies in the Light of Complex Cardiovascular Phenotypes: Implications for Clinical Practice

31. Is the Risk of Myocardial Infarction in People With Human Immunodeficiency Virus (HIV) Associated With Atazanavir or Darunavir? A Nested Case-Control Study Within the French Hospital Database on HIV

32. Evolocumab treatment in patients with HIV and hypercholesterolemia/mixed dyslipidemia: BEIJERINCK study design and baseline characteristics

33. P350 Right atrial remodelling in atrial fibrillation using three dimensional transthoracic echocardiography and strain imaging

34. Hospital Admissions for Acute Myocardial Infarction Before and After Lockdown According to Regional Prevalence of COVID-19 and Patient Profile

35. L’imagerie cardiovasculaire dans l’insuffisance cardiaque

36. Serum tryptophan-derived quinolinate and indole-3-acetate are associated with carotid intima-media thickness and its evolution in HIV-infected treated adults

37. Biatrial remodelling in atrial fibrillation: A three-dimensional and strain echocardiography insight

38. P5341Predictive factors of atherosclerotic cardiovascular diseases events in HIV-HVC co-infected patients: results from hepavih ANRS co13 cohort

39. P5338Atherosclerotic cardiovascular events in people living with Human Immunodeficiency Virus

40. HIV-related cardiovascular disease

41. Three dimensional right cardiac cavities remodeling and functional tricuspid regurgitation at one year follow up in patients with atrial fibrillation

42. THREE-DIMENSIONAL CARDIAC REMODELLING AFTER RESTORATION TO SINUS RHYTHM IN ATRIAL FIBRILLATION: ONE YEAR FOLLOW UP

43. EVOLOCUMAB USE IN PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS AND DYSLIPIDEMIA: FINAL RESULTS OF THE OPEN LABEL EXTENSION PERIOD (BEIJERINCK)

44. Cardiovascular health in an aging HIV population

45. Statin therapy and low-density lipoprotein cholesterol reduction in HIV-infected individuals after acute coronary syndrome: Results from the PACS-HIV lipids substudy

46. Reply

47. VIH y cardiopatía: ¿qué deben saber los cardiólogos?

48. Insuffisance cardiaque et chimiothérapie

49. Natural history of left atrial thrombus in atrial fibrillation patients

50. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

Catalog

Books, media, physical & digital resources